UK markets closed

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
26.000.00 (0.00%)
At close: 05:42PM CEST

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
https://www.bayer.com

Sector(s)Healthcare
IndustryDrug Manufacturers - General
Full-time employees98,189

Key executives

NameTitlePayExercisedYear born
Mr. William N. AndersonChairman of the Management Board & CEO8.43MN/A1966
Mr. Wolfgang U. NicklCFO & Member of Management Board1.98MN/A1969
Mr. Stefan OelrichHead of the Pharmaceuticals Division & Member of the Board of Management1.95MN/A1968
Mr. Rodrigo SantosMember of Management Board & President of the Crop Science Division2.17MN/A1973
Ms. Heike PrinzChief Talent Officer, Labor Director & Member of Management Board1.33MN/A1964
Mr. Julio TrianaMember of Management Board & President of Consumer Health DivisionN/AN/A1966
Dr. Sebastian Guth Ph.D.Chief Operating OfficerN/AN/AN/A
Dr. Jost ReinhardHead of Investor RelationsN/AN/A1972
Mr. Michael PreussHead of Communications, Government Relations and Corporate BrandN/AN/AN/A
Mr. Bernd-Peter BierHead of Group FinanceN/AN/A1967
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Corporate governance

Bayer Aktiengesellschaft’s ISS governance QualityScore as of 1 June 2024 is 3. The pillar scores are Audit: 10; Board: 3; Shareholder rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.